John E. Davis - 11 Mar 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)

Signature
/s/ John E. Davis
Issuer symbol
AORT
Transactions as of
11 Mar 2025
Net transactions value
-$13,688
Form type
4
Filing time
12 Mar 2025, 15:32:23 UTC
Previous filing
10 Mar 2025
Next filing
14 Aug 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AORT Common Stock Options Exercise $342,860 +15,910 +7.7% $21.55 223,878 11 Mar 2025 Direct F1
transaction AORT Common Stock Sale $356,549 -15,100 -6.7% $23.61 208,778 11 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AORT Stock Options (Right to buy) Options Exercise $0 -15,910 -100% $0.000000 0 11 Mar 2025 Common Stock 15,910 $21.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024.
F2 Reflects weighted average price. Range of prices were between $23.14 to $23.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.